• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is Androgen Deprivation Therapy "Another Deficient Therapy" for Gleason Score 9-10 Prostate Cancer?

作者信息

Deek Matthew P, Phillips Ryan M, Haffner Michael, Tran Phuoc T

机构信息

Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

Eur Urol. 2019 Jan;75(1):42-43. doi: 10.1016/j.eururo.2018.09.027. Epub 2018 Sep 26.

DOI:10.1016/j.eururo.2018.09.027
PMID:30268657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6330049/
Abstract
摘要

相似文献

1
Is Androgen Deprivation Therapy "Another Deficient Therapy" for Gleason Score 9-10 Prostate Cancer?雄激素剥夺疗法对 Gleason 评分 9 - 10 的前列腺癌来说是“另一种有缺陷的疗法”吗？
Eur Urol. 2019 Jan;75(1):42-43. doi: 10.1016/j.eururo.2018.09.027. Epub 2018 Sep 26.
2
Assessment of permanent brachytherapy combined with androgen deprivation therapy in an intermediate-risk prostate cancer group without a Gleason score of 4 + 3: a single Japanese institutional experience.评估无 Gleason 评分 4+3 的中危前列腺癌组中永久性近距离放射治疗联合雄激素剥夺治疗的效果：单中心日本经验。
Int J Urol. 2014 Mar;21(3):271-6. doi: 10.1111/iju.12245. Epub 2013 Aug 22.
3
The change in the dihydrotestosterone level in the prostate before and after androgen deprivation therapy in connection with prostate cancer aggressiveness using the Gleason score.使用Gleason评分，研究前列腺癌侵袭性与雄激素剥夺治疗前后前列腺中二氢睾酮水平的变化。
J Urol. 2007 Oct;178(4 Pt 1):1282-8; discussion 1288-9. doi: 10.1016/j.juro.2007.05.138. Epub 2007 Aug 14.
4
Understanding heterogeneity of treatment effect in prostate cancer.了解前列腺癌治疗效果的异质性。
Curr Opin Oncol. 2015 May;27(3):209-16. doi: 10.1097/CCO.0000000000000172.
5
Usefulness of J-CAPRA score for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapy.J-CAPRA 评分在碳离子放疗联合雄激素剥夺治疗高危前列腺癌患者中的应用价值。
Jpn J Clin Oncol. 2014 Apr;44(4):360-5. doi: 10.1093/jjco/hyu006. Epub 2014 Feb 28.
6
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.根治性前列腺切除术、外照射放疗、外照射放疗联合近距离放疗增敏与 Gleason 评分 9 - 10 前列腺癌患者的疾病进展及死亡率
JAMA. 2018 Mar 6;319(9):896-905. doi: 10.1001/jama.2018.0587.
7
Gleason score predicts androgen independent progression after androgen deprivation therapy.Gleason评分可预测雄激素剥夺治疗后雄激素非依赖性进展。
Eur Urol. 2002 Jul;42(1):12-7. doi: 10.1016/s0302-2838(02)00238-5.
8
Is Gleason Grade 5 Prostate Cancer Resistant to Conventional Androgen Deprivation Therapy?前列腺癌 Gleason 分级 5 是否对常规雄激素剥夺治疗有抵抗性？
Eur Urol. 2016 May;69(5):761-3. doi: 10.1016/j.eururo.2015.08.057. Epub 2015 Sep 11.
9
Gleason score 7 prostate cancer treated with interstitial brachytherapy with or without supplemental external beam radiation and androgen deprivation therapy: is the primary pattern on needle biopsy prognostic?
Brachytherapy. 2013 Jan-Feb;12(1):14-8. doi: 10.1016/j.brachy.2012.05.002. Epub 2012 Aug 9.
10
Osteoporosis and prostate cancer: a cross-sectional study of Danish men with prostate cancer before androgen deprivation therapy.骨质疏松症与前列腺癌：一项针对丹麦前列腺癌男性患者在雄激素剥夺治疗前的横断面研究。
Scand J Urol. 2014 Aug;48(4):350-5. doi: 10.3109/21681805.2014.884160. Epub 2014 Feb 19.

本文引用的文献

1
Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate Cancer.雄激素剥夺疗法与 Gleason 8 与 Gleason 9-10 前列腺癌患者的总生存。
Eur Urol. 2019 Jan;75(1):35-41. doi: 10.1016/j.eururo.2018.08.033. Epub 2018 Oct 24.
2
Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study.患者的临床结局格利森评分 10 前列腺腺癌：从一个多机构联盟研究的结果。
Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):883-888. doi: 10.1016/j.ijrobp.2018.03.060. Epub 2018 Apr 5.
3
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.根治性前列腺切除术、外照射放疗、外照射放疗联合近距离放疗增敏与 Gleason 评分 9 - 10 前列腺癌患者的疾病进展及死亡率
JAMA. 2018 Mar 6;319(9):896-905. doi: 10.1001/jama.2018.0587.
4
Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer.低前列腺特异性抗原、高级别前列腺癌的临床和基因组特征。
Eur Urol. 2018 Aug;74(2):146-154. doi: 10.1016/j.eururo.2018.01.043. Epub 2018 Feb 22.
5
Analytic, Preanalytic, and Clinical Validation of p53 IHC for Detection of Missense Mutation in Prostate Cancer.用于检测前列腺癌错义突变的p53免疫组化分析、分析前及临床验证
Clin Cancer Res. 2017 Aug 15;23(16):4693-4703. doi: 10.1158/1078-0432.CCR-17-0257. Epub 2017 Apr 26.
6
Very High-Risk Localized Prostate Cancer: Outcomes Following Definitive Radiation.极高风险局限性前列腺癌：根治性放疗后的结局
Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):254-62. doi: 10.1016/j.ijrobp.2015.10.056. Epub 2015 Oct 31.
7
Gleason Score 3 + 5 or 5 + 3 versus 4 + 4 Prostate Cancer: The Risk of Death.Gleason 评分 3+5 或 5+3 与 4+4 前列腺癌：死亡风险。
Eur Urol. 2016 Jun;69(6):976-9. doi: 10.1016/j.eururo.2015.08.054. Epub 2015 Sep 19.
8
Is Gleason Grade 5 Prostate Cancer Resistant to Conventional Androgen Deprivation Therapy?前列腺癌 Gleason 分级 5 是否对常规雄激素剥夺治疗有抵抗性？
Eur Urol. 2016 May;69(5):761-3. doi: 10.1016/j.eururo.2015.08.057. Epub 2015 Sep 11.
9
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.一种当代前列腺癌分级系统：格里森评分的有效替代方案。
Eur Urol. 2016 Mar;69(3):428-35. doi: 10.1016/j.eururo.2015.06.046. Epub 2015 Jul 10.
10
Integrative clinical genomics of advanced prostate cancer.晚期前列腺癌的整合临床基因组学
Cell. 2015 May 21;161(5):1215-1228. doi: 10.1016/j.cell.2015.05.001.